Members of eLab, Cornell’s student business accelerator, pitched their entrepreneurial ideas to business leaders, mentors and alumni at the annual eLab NYC Pitch Night, Nov. 7 at the World Trade Center.
The Eclectic Convergence Entrepreneurship Summit, held Nov. 8 in New York City, drew 550 attendees for TED-style talks from entrepreneurs and venture capitalists, plus lots of networking.
A protein that breast, lung and other cancers use to promote their spread – or metastasis – to the brain, has been identified by a team led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Professors Holly Prigerson and Valerie Reyna have combined forces to study end-of-life communication between patients and their physicians and clinicians, with the goal of improved prognostic understanding and decision-making and, ultimately, better end-of-life decisions.
Professors Holly Prigerson and Valerie Reyna have combined forces to study end-of-life communication between patients and their physicians and clinicians, with the goal of improved prognostic understanding and decision-making and, ultimately, better end-of-life decisions.
A team of Cornell researchers and scientists focused on pain management has received a five-year, $3 million grant from the National Institute on Aging, part of the National Institutes of Health.
New cellular and molecular processes underlying communication between gut microbes and brain cells have been described for the first time by scientists at Weill Cornell Medicine and Cornell’s Ithaca campus.
Dr. Rainu Kaushal, chair of the Department of Healthcare Policy and Research at Weill Cornell Medicine, has been elected to the National Academy of Medicine
